Most Read Articles
Roshini Claire Anthony, 5 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 6 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
4 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.

Mastectomy tied to poor QoL in young women with breast cancer

Elaine Soliven
10 Jan 2019

Younger women with breast cancer who had a mastectomy demonstrated a worse quality of life (QoL) compared with those who underwent breast-conserving surgery (BCS), according to a study presented at SABCS 2018.

“Historically, about 75 percent of women are eligible for BCS. However, over time, more women, and particularly young women, are electing for bilateral mastectomy,” said lead author Dr Laura Dominici from Brigham and Women's Hospital, Boston, Massachusetts, US, who found that mastectomy, especially unilateral or bilateral, was associated with a significant decrease in QoL than BCS.

Using data from the YWS* database, the researchers conducted a prospective cohort study involving 560 young women with breast cancer (median age at diagnosis, 37 years) from 12 hospitals in the US. BREAST-Q domains, such as psychosocial, sexual, and physical wellbeing as well as breast satisfaction, were assessed to validate the patient-reported outcomes across three different surgeries. The most common type of surgery was bilateral mastectomy at 52 percent, followed by BCS at 28 percent, and unilateral mastectomy at 20 percent. [SABCS 2018, abstract GS6-06]

Women who underwent mastectomy had a significantly worse QoL than those who had a BCS, as shown by lower BREAST-Q scores for psychosocial wellbeing (mean score, 68.4 and 70.6 for bilateral and unilateral, respectively, vs 75.9; p<0.001) and sexual wellbeing (mean score, 49 and 53.4 for bilateral and unilateral, respectively, vs 57.4; p<0.001).

A significantly lower BREAST-Q score for breast satisfaction was also observed among women who had a mastectomy compared with those who had a BCS (mean score, 60.4 for bilateral and 59.3 for unilateral vs 65.5; p=0.008).

With regard to physical wellbeing, there was no significant BREAST-Q score difference across all surgeries (mean score, 78.7 for bilateral and 78.9 for unilateral mastectomies vs 78.9 for BCS; p=0.8).

Moreover, a multivariate analysis showed that patients who had a BMI of ≥25 kg/m2 demonstrated a decrease in QoL domains, indicating a negative beta score difference in BREAST-Q score, for psychosocial (ß, -4.2; p=0.03) and sexual wellbeing (ß, -5.3; p=0.006).

“Local therapy decisions are associated with a persistent impact on QoL in young breast cancer survivors,” said Dominici, who added that “knowledge of the potential long-term impact of surgery on QoL is of critical importance for counselling young women about surgical decisions.”

“We really need to have more data about QoL, particularly after surgery, because this information can help shape their decisions,” she added.

 

*YWS: Young Women’s Breast Cancer Study

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 5 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 6 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
4 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.